Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients

Author： Alavian S.M.   Hajarizadeh B.   Einollahi B.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.35, Iss.7, 2003-11, pp. : 2687-2688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of chronic hepatitis B with lamivudine in renal allograft recipients

By Lewandowska D.   Durlik M.   Kukula K.   Cieciura T.   Ciecierski R.   Walewska-Zielecka B.   Szmidt J.   Rowinski W.   Lao M.  

Transplantation Proceedings, Vol. 32, Iss. 6, 2000-09 ,pp. : 1369-1370

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B

By Antoine C.   Landau A.   Menoyo V.   Duong J.P.   Duboust A.   Glotz D.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 384-385

Elsevier

Access to resources Recommend Favorite

Lamivudine therapy in renal allograft recipients with hepatitis B virus infection

By Tsang W.K.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 278-279

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients

By Tsang W.K.   Tong K.L.   Yeung S.   Lee W.   Chan H.W.H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1755-1756

Elsevier

Access to resources Recommend Favorite

Lamivudine in renal transplant candidates with chronic hepatitis B infection

By Boyacioglu S.   Gur G.   Gursoy M.   Ozdemir N.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2131-2132

Elsevier

Access to resources Recommend Favorite